لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Zaniletti I; IZ Statistics LLC, Tampa, Florida., Gunn HJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota., Hallemeier CL; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Laughlin BS; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona., Leavitt TR; Cytel, Cambridge, Massachusetts., Haddock MG; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Merrell KW; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Leenstra JL; Department of Radiation Oncology, Mayo Clinic, Northfield, Minnesota., May BC; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida., Ashman JB; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida., DeWees TA; Department of Computational and Quantitative Medicine, City of Hope, Duarte, California. Electronic address: tdewees@coh.org.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Jan 01; Vol. 118 (1), pp. 137-141. Date of Electronic Publication: 2023 Aug 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Quality of Life* , Pancreatic Neoplasms*/radiotherapy, Humans ; Minimal Clinically Important Difference ; Health Status ; Surveys and Questionnaires ; Pancreatic Neoplasms

المؤلفون: Yoon HH; Mayo Clinic, Rochester, MN, USA. Electronic address: Yoon.Harry@mayo.edu., Ou FS; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA. Electronic address: Ou.Fang-Shu@mayo.edu., Soori GS; Missouri Valley Cancer Consortium, Omaha, NE, USA. Electronic address: gsoori@nebraskacancer.com., Shi Q; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA. Electronic address: Shi.Qian2@mayo.edu., Wigle DA; Mayo Clinic, Rochester, MN, USA. Electronic address: Wigle.Dennis@mayo.edu., Sticca RP; Sanford Clinic North-Fargo, Fargo, ND, USA. Electronic address: robert.sticca@med.und.edu., Miller RC; Mayo Clinic, Rochester, MN, USA. Electronic address: miller.robert@mayo.edu., Leenstra JL; Mayo Clinic, Rochester, MN, USA. Electronic address: Leenstra.James@mayo.edu., Peller PJ; Mayo Clinic, Rochester, MN, USA. Electronic address: peller.patrick@mayo.edu., Ginos B; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA. Electronic address: Ginos.Brenda@mayo.edu., Heying E; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA. Electronic address: Heying.Erica@mayo.edu., Wu TT; Mayo Clinic, Rochester, MN, USA. Electronic address: Wu.TsungTeh@mayo.edu., Drevyanko TF; UnityPoint Health, Des Moines, IA, USA. Electronic address: timothy.drevyanko@unitypoint.org., Ko S; Mayo Clinic, Jacksonville, FL, USA. Electronic address: Ko.Stephen@mayo.edu., Mattar BI; Cancer Center of Kansas - Wichita, Wichita, KS, USA. Electronic address: bmattar@msn.com., Nikcevich DA; Duluth Community Clinical Oncology Program (COOP), Duluth, MN, USA. Electronic address: daniel.nikcevich@essentiahealth.org., Behrens RJ; Iowa Wide Oncology Research Coalition, Des Moines, IA, USA. Electronic address: rbehrens@cancercenterofiowa.com., Khalil MF; Lehigh Valley Health Network, Allentown, Michigan Cancer Research Consortium, PA, USA. Electronic address: Maged.Khalil@lvhn.org., Kim GP; 21(st) Century Oncology of Jacksonville, Jacksonville, FL, USA. Electronic address: george.kim@21co.com., Alberts SR; Mayo Clinic, Rochester, MN, USA. Electronic address: alberts.steven@mayo.edu.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Jun; Vol. 150, pp. 214-223. Date of Electronic Publication: 2021 Apr 29.

نوع المنشور: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Chemoradiotherapy, Adjuvant*/adverse effects , Chemoradiotherapy, Adjuvant*/mortality , Esophagectomy*/adverse effects , Esophagectomy*/mortality , Induction Chemotherapy*/adverse effects , Induction Chemotherapy*/mortality , Neoadjuvant Therapy*/adverse effects , Neoadjuvant Therapy*/mortality, Adenocarcinoma/*therapy , Esophageal Neoplasms/*therapy, Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adult ; Aged ; Aged, 80 and over ; Cell Differentiation ; Disease-Free Survival ; Esophageal Neoplasms/mortality ; Esophageal Neoplasms/pathology ; Female ; Humans ; Male ; Middle Aged ; Time Factors ; United States

SCR Disease Name: Adenocarcinoma Of Esophagus

المؤلفون: Yu NY; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA., Sio TT; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA., Lyons MK; Department of Neurological Surgery, Mayo Clinic, Phoenix, AZ, USA., Vora SA; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA., Turkmani A; Department of Neurological Surgery, Mayo Clinic, Phoenix, AZ, USA., Brown PD; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Park SS; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Leenstra JL; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Bendok BR; Department of Neurological Surgery, Mayo Clinic, Phoenix, AZ, USA., Schild SE; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA., Ashman JB; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA. Electronic address: Ashman.Jonathan@mayo.edu.

المصدر: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2020 Oct; Vol. 80, pp. 74-78. Date of Electronic Publication: 2020 Aug 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 9433352 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2653 (Electronic) Linking ISSN: 09675868 NLM ISO Abbreviation: J Clin Neurosci Subsets: MEDLINE

مواضيع طبية MeSH: Hemangioma/*radiotherapy , Radiosurgery/*methods , Radiotherapy Planning, Computer-Assisted/*methods , Spinal Neoplasms/*radiotherapy, Adult ; Aged ; Dose Fractionation, Radiation ; Female ; Humans ; Male ; Middle Aged ; Particle Accelerators ; Vertebral Body/pathology

المؤلفون: Sio TT; Department of Radiation Oncology, Mayo Clinic Hospital, Phoenix, Arizona., Le-Rademacher JG; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Leenstra JL; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Loprinzi CL; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Rine G; Wichita National Cancer Institute Community Oncology Research Program, Wichita, Kansas., Curtis A; Southeast Clinical Oncology Research Consortium National Cancer Institute Community Oncology Research Program, Spartanburg, South Carolina., Singh AK; Roswell Park Cancer Institute, Buffalo, New York., Martenson JA Jr; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Novotny PJ; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Tan AD; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Qin R; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Ko SJ; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida., Reiter PL; Ohio State University Medical Center, Columbus., Miller RC; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida.; Now with the University of Maryland School of Medicine, Baltimore.

المصدر: JAMA [JAMA] 2019 Apr 16; Vol. 321 (15), pp. 1481-1490.

نوع المنشور: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Mouthwashes*, Antacids/*therapeutic use , Diphenhydramine/*therapeutic use , Doxepin/*therapeutic use , Head and Neck Neoplasms/*radiotherapy , Lidocaine/*therapeutic use , Radiation Injuries/*drug therapy , Stomatitis/*drug therapy, Administration, Topical ; Adult ; Aged ; Aged, 80 and over ; Diphenhydramine/adverse effects ; Double-Blind Method ; Doxepin/adverse effects ; Fatigue/chemically induced ; Female ; Humans ; Lidocaine/adverse effects ; Linear Models ; Male ; Middle Aged ; Pain/drug therapy ; Stomatitis/etiology

المؤلفون: Sio TT; Department of Radiation Oncology, Mayo Clinic Hospital, Phoenix, Arizona. Electronic address: Sio.Terence@mayo.edu., Atherton PJ; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota., Pederson LD; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota., Zhen WK; Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, Nebraska., Mutter RW; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Garces YI; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Ma DJ; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Leenstra JL; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Rwigema JM; Department of Radiation Oncology, Mayo Clinic Hospital, Phoenix, Arizona., Dakhil S; Department of Radiation Oncology, Cancer Center of Kansas, Wichita, Kansas., Bearden JD; Department of Radiation Oncology, Spartanburg Medical Center, Spartanburg, South Carolina., van der Veen SJ; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., Ganti AK; Division of Oncology-Hematology, Department of Internal Medicine, VA Nebraska Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska., Schild SE; Department of Radiation Oncology, Mayo Clinic Hospital, Phoenix, Arizona., Miller RC; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2019 Mar 01; Vol. 103 (3), pp. 686-696. Date of Electronic Publication: 2018 Nov 02.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Chemoradiotherapy/*methods , Lisinopril/*pharmacology , Lung Neoplasms/*drug therapy , Lung Neoplasms/*radiotherapy , Radiation Injuries/*prevention & control , Radiation Pneumonitis/*prevention & control, Aged ; Aged, 80 and over ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Chemoradiotherapy/adverse effects ; Double-Blind Method ; Dyspnea/pathology ; Female ; Humans ; Lung/drug effects ; Lung/radiation effects ; Male ; Middle Aged ; Patient Safety ; Pilot Projects ; Placebos ; Quality of Life ; Radiation Injuries/etiology ; Radiation Pneumonitis/etiology ; Radiotherapy/methods ; Surveys and Questionnaires ; Treatment Outcome

المؤلفون: Whitaker TJ; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA., Mayo CS; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA., Ma DJ; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA., Haddock MG; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA., Miller RC; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, USA., Corbin KS; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA., Neben-Wittich M; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA., Leenstra JL; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA., Laack NN; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA., Fatyga M; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA., Schild SE; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA., Vargas CE; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA., Tzou KS; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, USA., Hadley AR; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, USA., Buskirk SJ; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, USA., Foote RL; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.

المصدر: Journal of radiation research [J Radiat Res] 2018 Mar 01; Vol. 59 (suppl_1), pp. i19-i24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0376611 Publication Model: Print Cited Medium: Internet ISSN: 1349-9157 (Electronic) Linking ISSN: 04493060 NLM ISO Abbreviation: J Radiat Res Subsets: MEDLINE

مواضيع طبية MeSH: Data Collection* , Patient Reported Outcome Measures*, Humans ; Time Factors ; Treatment Outcome

المؤلفون: Katz MHG; The University of Texas MD Anderson Cancer Center, University of Texas, 1400 Pressler Street FCT 17.6058, Unit #1484, Houston, TX, 77030-4009, USA. mhgkatz@mdanderson.org., Ou FS; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA., Herman JM; The University of Texas MD Anderson Cancer Center, University of Texas, 1400 Pressler Street FCT 17.6058, Unit #1484, Houston, TX, 77030-4009, USA., Ahmad SA; University of Cincinnati, Cincinnati, OH, USA., Wolpin B; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Marsh R; NorthShore Evanston Hospital, Evanston, IL, USA., Behr S; The University of California at San Francisco, San Francisco, CA, USA., Shi Q; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA., Chuong M; University of Maryland/Greenebaum Cancer Center, Baltimore, MD, USA., Schwartz LH; New York-Presbyterian Hospital/Columbia University Medical Center, New York, NY, USA., Frankel W; The Ohio State University, Columbus, OH, USA., Collisson E; The University of California at San Francisco, San Francisco, CA, USA., Koay EJ; The University of Texas MD Anderson Cancer Center, University of Texas, 1400 Pressler Street FCT 17.6058, Unit #1484, Houston, TX, 77030-4009, USA., Hubbard JM; Mayo Clinic, Rochester, MN, USA., Leenstra JL; Mayo Clinic, Rochester, MN, USA., Meyerhardt J; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., O'Reilly E; Memorial Sloan Kettering Cancer Center, New York, NY, USA.

مؤلفون مشاركون: Alliance for Clinical Trials on Oncology

المصدر: BMC cancer [BMC Cancer] 2017 Jul 27; Vol. 17 (1), pp. 505. Date of Electronic Publication: 2017 Jul 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma/*therapy , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Pancreatic Neoplasms/*therapy, Camptothecin/administration & dosage ; Camptothecin/analogs & derivatives ; Clinical Trials, Phase II as Topic ; Combined Modality Therapy ; Fluorouracil/administration & dosage ; Humans ; Irinotecan ; Leucovorin/administration & dosage ; Multicenter Studies as Topic ; Organoplatinum Compounds/administration & dosage ; Oxaliplatin ; Pancreatectomy ; Radiation Dose Hypofractionation ; Randomized Controlled Trials as Topic

المؤلفون: Leenstra JL; James L. Leenstra, St Vincent Regional Cancer Center, Green Bay, WI; Robert C. Miller, Rui Qin, James A. Martenson, Paul J. Novotny, Robert L. Foote, and Charles L. Loprinzi, Mayo Clinic, Rochester; Kenneth J. Dornfeld, Essentia Health Cancer Center, Duluth, MN; James D. Bearden, Palmetto Hematology Oncology, Spartanburg, SC; Dev R. Puri, Mercy Cancer Center, Des Moines, IA; Philip J. Stella, St Joseph Mercy Cancer Care Center, Ann Arbor, MI; Miroslaw A. Mazurczak, Sandford Health Cancer Center, Sioux Falls, SD; and Marie D. Klish, Hope Cancer Center, Longmont, CO., Miller RC; James L. Leenstra, St Vincent Regional Cancer Center, Green Bay, WI; Robert C. Miller, Rui Qin, James A. Martenson, Paul J. Novotny, Robert L. Foote, and Charles L. Loprinzi, Mayo Clinic, Rochester; Kenneth J. Dornfeld, Essentia Health Cancer Center, Duluth, MN; James D. Bearden, Palmetto Hematology Oncology, Spartanburg, SC; Dev R. Puri, Mercy Cancer Center, Des Moines, IA; Philip J. Stella, St Joseph Mercy Cancer Care Center, Ann Arbor, MI; Miroslaw A. Mazurczak, Sandford Health Cancer Center, Sioux Falls, SD; and Marie D. Klish, Hope Cancer Center, Longmont, CO. miller.robert@mayo.edu., Qin R; James L. Leenstra, St Vincent Regional Cancer Center, Green Bay, WI; Robert C. Miller, Rui Qin, James A. Martenson, Paul J. Novotny, Robert L. Foote, and Charles L. Loprinzi, Mayo Clinic, Rochester; Kenneth J. Dornfeld, Essentia Health Cancer Center, Duluth, MN; James D. Bearden, Palmetto Hematology Oncology, Spartanburg, SC; Dev R. Puri, Mercy Cancer Center, Des Moines, IA; Philip J. Stella, St Joseph Mercy Cancer Care Center, Ann Arbor, MI; Miroslaw A. Mazurczak, Sandford Health Cancer Center, Sioux Falls, SD; and Marie D. Klish, Hope Cancer Center, Longmont, CO., Martenson JA; James L. Leenstra, St Vincent Regional Cancer Center, Green Bay, WI; Robert C. Miller, Rui Qin, James A. Martenson, Paul J. Novotny, Robert L. Foote, and Charles L. Loprinzi, Mayo Clinic, Rochester; Kenneth J. Dornfeld, Essentia Health Cancer Center, Duluth, MN; James D. Bearden, Palmetto Hematology Oncology, Spartanburg, SC; Dev R. Puri, Mercy Cancer Center, Des Moines, IA; Philip J. Stella, St Joseph Mercy Cancer Care Center, Ann Arbor, MI; Miroslaw A. Mazurczak, Sandford Health Cancer Center, Sioux Falls, SD; and Marie D. Klish, Hope Cancer Center, Longmont, CO., Dornfeld KJ; James L. Leenstra, St Vincent Regional Cancer Center, Green Bay, WI; Robert C. Miller, Rui Qin, James A. Martenson, Paul J. Novotny, Robert L. Foote, and Charles L. Loprinzi, Mayo Clinic, Rochester; Kenneth J. Dornfeld, Essentia Health Cancer Center, Duluth, MN; James D. Bearden, Palmetto Hematology Oncology, Spartanburg, SC; Dev R. Puri, Mercy Cancer Center, Des Moines, IA; Philip J. Stella, St Joseph Mercy Cancer Care Center, Ann Arbor, MI; Miroslaw A. Mazurczak, Sandford Health Cancer Center, Sioux Falls, SD; and Marie D. Klish, Hope Cancer Center, Longmont, CO., Bearden JD; James L. Leenstra, St Vincent Regional Cancer Center, Green Bay, WI; Robert C. Miller, Rui Qin, James A. Martenson, Paul J. Novotny, Robert L. Foote, and Charles L. Loprinzi, Mayo Clinic, Rochester; Kenneth J. Dornfeld, Essentia Health Cancer Center, Duluth, MN; James D. Bearden, Palmetto Hematology Oncology, Spartanburg, SC; Dev R. Puri, Mercy Cancer Center, Des Moines, IA; Philip J. Stella, St Joseph Mercy Cancer Care Center, Ann Arbor, MI; Miroslaw A. Mazurczak, Sandford Health Cancer Center, Sioux Falls, SD; and Marie D. Klish, Hope Cancer Center, Longmont, CO., Puri DR; James L. Leenstra, St Vincent Regional Cancer Center, Green Bay, WI; Robert C. Miller, Rui Qin, James A. Martenson, Paul J. Novotny, Robert L. Foote, and Charles L. Loprinzi, Mayo Clinic, Rochester; Kenneth J. Dornfeld, Essentia Health Cancer Center, Duluth, MN; James D. Bearden, Palmetto Hematology Oncology, Spartanburg, SC; Dev R. Puri, Mercy Cancer Center, Des Moines, IA; Philip J. Stella, St Joseph Mercy Cancer Care Center, Ann Arbor, MI; Miroslaw A. Mazurczak, Sandford Health Cancer Center, Sioux Falls, SD; and Marie D. Klish, Hope Cancer Center, Longmont, CO., Stella PJ; James L. Leenstra, St Vincent Regional Cancer Center, Green Bay, WI; Robert C. Miller, Rui Qin, James A. Martenson, Paul J. Novotny, Robert L. Foote, and Charles L. Loprinzi, Mayo Clinic, Rochester; Kenneth J. Dornfeld, Essentia Health Cancer Center, Duluth, MN; James D. Bearden, Palmetto Hematology Oncology, Spartanburg, SC; Dev R. Puri, Mercy Cancer Center, Des Moines, IA; Philip J. Stella, St Joseph Mercy Cancer Care Center, Ann Arbor, MI; Miroslaw A. Mazurczak, Sandford Health Cancer Center, Sioux Falls, SD; and Marie D. Klish, Hope Cancer Center, Longmont, CO., Mazurczak MA; James L. Leenstra, St Vincent Regional Cancer Center, Green Bay, WI; Robert C. Miller, Rui Qin, James A. Martenson, Paul J. Novotny, Robert L. Foote, and Charles L. Loprinzi, Mayo Clinic, Rochester; Kenneth J. Dornfeld, Essentia Health Cancer Center, Duluth, MN; James D. Bearden, Palmetto Hematology Oncology, Spartanburg, SC; Dev R. Puri, Mercy Cancer Center, Des Moines, IA; Philip J. Stella, St Joseph Mercy Cancer Care Center, Ann Arbor, MI; Miroslaw A. Mazurczak, Sandford Health Cancer Center, Sioux Falls, SD; and Marie D. Klish, Hope Cancer Center, Longmont, CO., Klish MD; James L. Leenstra, St Vincent Regional Cancer Center, Green Bay, WI; Robert C. Miller, Rui Qin, James A. Martenson, Paul J. Novotny, Robert L. Foote, and Charles L. Loprinzi, Mayo Clinic, Rochester; Kenneth J. Dornfeld, Essentia Health Cancer Center, Duluth, MN; James D. Bearden, Palmetto Hematology Oncology, Spartanburg, SC; Dev R. Puri, Mercy Cancer Center, Des Moines, IA; Philip J. Stella, St Joseph Mercy Cancer Care Center, Ann Arbor, MI; Miroslaw A. Mazurczak, Sandford Health Cancer Center, Sioux Falls, SD; and Marie D. Klish, Hope Cancer Center, Longmont, CO., Novotny PJ; James L. Leenstra, St Vincent Regional Cancer Center, Green Bay, WI; Robert C. Miller, Rui Qin, James A. Martenson, Paul J. Novotny, Robert L. Foote, and Charles L. Loprinzi, Mayo Clinic, Rochester; Kenneth J. Dornfeld, Essentia Health Cancer Center, Duluth, MN; James D. Bearden, Palmetto Hematology Oncology, Spartanburg, SC; Dev R. Puri, Mercy Cancer Center, Des Moines, IA; Philip J. Stella, St Joseph Mercy Cancer Care Center, Ann Arbor, MI; Miroslaw A. Mazurczak, Sandford Health Cancer Center, Sioux Falls, SD; and Marie D. Klish, Hope Cancer Center, Longmont, CO., Foote RL; James L. Leenstra, St Vincent Regional Cancer Center, Green Bay, WI; Robert C. Miller, Rui Qin, James A. Martenson, Paul J. Novotny, Robert L. Foote, and Charles L. Loprinzi, Mayo Clinic, Rochester; Kenneth J. Dornfeld, Essentia Health Cancer Center, Duluth, MN; James D. Bearden, Palmetto Hematology Oncology, Spartanburg, SC; Dev R. Puri, Mercy Cancer Center, Des Moines, IA; Philip J. Stella, St Joseph Mercy Cancer Care Center, Ann Arbor, MI; Miroslaw A. Mazurczak, Sandford Health Cancer Center, Sioux Falls, SD; and Marie D. Klish, Hope Cancer Center, Longmont, CO., Loprinzi CL; James L. Leenstra, St Vincent Regional Cancer Center, Green Bay, WI; Robert C. Miller, Rui Qin, James A. Martenson, Paul J. Novotny, Robert L. Foote, and Charles L. Loprinzi, Mayo Clinic, Rochester; Kenneth J. Dornfeld, Essentia Health Cancer Center, Duluth, MN; James D. Bearden, Palmetto Hematology Oncology, Spartanburg, SC; Dev R. Puri, Mercy Cancer Center, Des Moines, IA; Philip J. Stella, St Joseph Mercy Cancer Care Center, Ann Arbor, MI; Miroslaw A. Mazurczak, Sandford Health Cancer Center, Sioux Falls, SD; and Marie D. Klish, Hope Cancer Center, Longmont, CO.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2014 May 20; Vol. 32 (15), pp. 1571-7. Date of Electronic Publication: 2014 Apr 14.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Acute Pain/*drug therapy , Analgesics/*administration & dosage , Chemoradiotherapy/*adverse effects , Cranial Irradiation/*adverse effects , Doxepin/*administration & dosage , Facial Pain/*drug therapy , Head and Neck Neoplasms/*radiotherapy , Stomatitis/*drug therapy, Acute Pain/chemically induced ; Acute Pain/diagnosis ; Adult ; Aged ; Aged, 80 and over ; Analgesics/adverse effects ; Area Under Curve ; Cross-Over Studies ; Double-Blind Method ; Doxepin/adverse effects ; Facial Pain/chemically induced ; Facial Pain/diagnosis ; Female ; Head and Neck Neoplasms/drug therapy ; Humans ; Male ; Middle Aged ; Mouthwashes ; Pain Measurement ; Predictive Value of Tests ; Stomatitis/chemically induced ; Stomatitis/diagnosis ; Surveys and Questionnaires ; Time Factors ; Treatment Outcome ; United States

المؤلفون: Leenstra JL; Department of Radiation Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA., Tanaka S, Kline RW, Brown PD, Link MJ, Nippoldt TB, Young WF Jr, Pollock BE

المصدر: Neurosurgery [Neurosurgery] 2010 Jul; Vol. 67 (1), pp. 27-32; discussion 32-3.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins, Inc Country of Publication: United States NLM ID: 7802914 Publication Model: Print Cited Medium: Internet ISSN: 1524-4040 (Electronic) Linking ISSN: 0148396X NLM ISO Abbreviation: Neurosurgery Subsets: MEDLINE

مواضيع طبية MeSH: Adenoma/*surgery , Hypopituitarism/*etiology , Pituitary Gland, Anterior/*radiation effects , Pituitary Gland, Anterior/*surgery , Pituitary Neoplasms/*surgery , Postoperative Complications/*etiology , Radiosurgery/*adverse effects, Adenoma/diagnostic imaging ; Adenoma/pathology ; Humans ; Hypopituitarism/physiopathology ; Hypopituitarism/prevention & control ; Pituitary Gland, Anterior/physiopathology ; Pituitary Neoplasms/diagnostic imaging ; Pituitary Neoplasms/pathology ; Postoperative Complications/epidemiology ; Postoperative Complications/prevention & control ; Prospective Studies ; Radiography ; Radiosurgery/methods ; Retrospective Studies ; Risk Assessment ; Risk Factors